Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|October 6, 2000
A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancerR Pelley, R Ganapathi, L Wood, et al.
Cancer|March 15, 1996
Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinomaE Wos, T Olencki, L Tuason, et al.
Investigational New Drugs|May 1, 1993
Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinomaR M Bukowski, J Young, G Goodman, et al.
Science (New York, N.Y.)|April 25, 1980
Somatomedin C: restoration in vivo of cycle traverse in G0/G1 blocked cells of hypophysectomized animalsH Rothstein, J J Van Wyk, J H Hayden, et al.
AJNR. American Journal of Neuroradiology|December 14, 2019
Differentiation between Tuberculous and Pyogenic Spondylodiscitis: The Role of the Anterior Meningovertebral Ligament in Patients with Anterior Epidural AbscessS B Strauss, S R Gordon, J Burns, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of WR-2721 and carboplatinG T Budd, R Ganapathi, L Bauer, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effectsR M Bukowski, S A Murthy, J Finke, et al.
Cancer|September 26, 1997
Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumorsG T Budd, R Ganapathi, D J Adelstein, et al.
European Journal of Cell Biology|August 1, 1990
Thrombospondin: biosynthesis, distribution, and changes associated with wound repair in corneal endotheliumI D Munjal, D R Crawford, D A Blake, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 4, 1993
Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effectsR M Bukowski, S Murthy, D McLain, et al.
Pageof 9